The Food and Drug Administration has released a follow-up to previous concerns about the safety of using the diet drug Meridia.
The notice was sent to cardiologist and endocrinologist healthcare professionals in Indiana and around the nation warning of the increased risk of heart attack and stroke with the use of sibutramine, the generic name of Meridia. This increase was seen in patients who had a history of cardiovascular disease.
Meridia’s drug label must now carry a new contradiction stating that those with certain health histories should not use Meridia, including those with a history of coronary artery disease, stroke, transient ischemic attack, heart arrhythmias, congestive heart failure, peripheral arterial disease or uncontrolled hypertension.
What is Meridia? Meridia, or sibutramine, is prescribed to people who are obese as part of a diet and exercise plan. It affects certain chemicals in the brain that are responsible for weight control.
The FDA is urging patients who currently use sibutramine to speak with their healthcare provider to see if there are risks in continuing the medication.